fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Ltd

Updated on July 10, 2019

Stock/Share Code - SPARC

Sun Pharma Advanced Research Company is in the business of research & development of pharmaceutical products.

Below is the details of SPARC Sun Pharma Advanced Research Company Ltd

Market Cap₹3,885 Cr.
Current Price ₹143.4 as on 16 Jul 19
52 Week High / Low Price₹438 / ₹130
Face Value₹1
Stock P/E
Book Value₹11.3
Dividend Yield0.00 %
ROCE-195 %
ROE-199 %
Sales Growth (3yrs)-20.50 %
SectorMiscellaneous
IndustryMiscellaneous
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has reduced debt. Company is virtually debt free. Company is expected to give good quarter
Cons: Stock is trading at 13.11 times its book value Company has low interest coverage ratio. The company has delivered a poor growth of -2.16% over past five years. Company has a low return on equity of -154.29% for last 3 years.

Sun Pharma Advanced Research Company Ltd Price Chart

Sun Pharma Advanced Research Company Ltd Price Chart

Sun Pharma Advanced Research Company Ltd Peer Comparison in Miscellaneous

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Info Edg.(India) ₹2,257.4 99.41 ₹25,074.11 Cr. 0.27 Cr. 15.04
2. Gujarat Gas ₹162.6 29.47 ₹12,659.49 Cr. 0.44 ₹116.54 Cr. 76.71 10.03 1907.55 16.55
3. Security & Intel ₹38.3 31.09 ₹6,699.31 Cr. 0.38 ₹72.63 Cr. 116.87 22.78 1954.85 19.51
4. Team Lease Serv. ₹2,999.65 52.34 ₹5,129.97 Cr. 0.00 ₹26.02 Cr. 22.62 19.02 1163.38 18.38
5. Just Dial ₹747 23.97 ₹4,957.8 Cr. 0.00 ₹62.55 Cr. 60.55 15.86 232.26 21.48
6. SPARC ₹3,884.85 Cr. 0.00 -₹9.35 Cr. 79.89 322.25 84.83 -194.72
7. Century Ply. ₹206.2 23.91 ₹3,795.83 Cr. 0.59 ₹34.16 Cr. -4.37 7.19 583.23 17.08

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Sun Pharma Advanced Research Company Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019
Sales21.4894.8923.0541.6023.3915.3619.4220.0916.8161.3519.8884.83
YOY Sales Growth %-50.55%120.06%-31.3%1.04%8.89%-83.81%-15.75%-51.71%-28.13%299.41%2.37%322.25%
Expenses57.3281.3889.8575.16101.3676.8477.6065.0880.6066.5590.2696.75
Material Cost %19.65%9.77%37.66%7.24%65.93%6.45%27.03%25.63%17.13%3.34%23.19%3.52%
Employee Cost %94.32%23.5%94.49%47.38%107.87%173.7%127.29%120.96%121.53%32.5%107.44%22.79%
Operating Profit-35.8413.51-66.80-33.56-77.97-61.48-58.18-44.99-63.79-5.20-70.38-11.92
OPM %-166.85%14.24%-289.80%-80.67%-333.35%-400.26%-299.59%-223.94%-379.48%-8.48%-354.02%-14.05%
Other Income3.024.042.903.781.261.012.1549.501.234.573.284.43
Interest1.360.430.030.030.070.020.020.010.020.010.020.04
Depreciation1.962.112.092.082.062.082.022.021.901.941.901.82
Profit before tax-36.1415.01-66.02-31.89-78.84-62.57-58.072.48-64.48-2.58-69.02-9.35
Tax %-0.00%0.00%-0.00%-0.00%-0.00%-0.00%-0.00%0.00%-0.00%-0.00%-0.00%-0.00%
Net Profit-36.1415.01-66.02-31.89-78.84-62.57-58.072.48-64.48-2.58-69.02-9.35
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018TTM
Sales037353458298716715616118178183
Sales Growth %%%-6.19%-2.39%70.12%-50.33%201.17%91.37%-6.76%3.56%12.24%-56.77%%
Expenses24145536599104134191224304321334
Material Cost %%18.31%21.51%19.71%13.16%25.6%10.67%4.8%6.49%11.7%13.9%34.26%%
Manufacturing Cost %%11.51%22.03%22.27%13.62%29.95%11.94%7.42%79.59%81.83%82.62%167.58%%
Employee Cost %%33.13%43.26%58.08%40.05%105%41.88%24.19%29.4%35.09%46.57%128.95%%
Other Cost %%46%42.52%55.48%44.51%180.81%54.72%43.55%7.05%10.52%24.69%79.21%%
Operating Profit-2-3-10-19-7-70-1734-35-63-123-243-151
OPM %-9%-29%-56%-11%-241%-19%20%-23%-39%-68%-310%-83%
Other Income00-001121033145414
Interest0000004602200
Depreciation0123333478888
Profit before tax-2-5-12-22-8-72-2234-40-70-119-197-145
Tax %-171%-7%27%-0%-0%-0%-0%12%-0%-0%-0%-0%
Net Profit-5-5-9-22-8-72-2230-40-70-119-197-145
EPS in Rs0.000.000.000.000.000.001.270.000.000.000.00
Dividend Payout %-0%-0%-0%-0%-0%-0%-0%0%-0%-0%-0%-0%

Compounded Sales Growth

  • 10 Years:: 7.65%
  • 5 Years:: -2.16%
  • 3 Years:: -20.50%
  • TTM:: 133.67%

Compounded Profit Growth

  • 10 Years:: 48.26%
  • 5 Years:: 60.67%
  • 3 Years:: 84.63%
  • TTM:: -26.18%

Return on Equity

  • 5 Years:: -85.70%
  • 3 Years:: -154.29%
  • Last Year:: -199.02%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Share Capital19212121212124242424252526
Equity Capital020.7120.7120.7120.7120.7123.6623.6723.6723.6724.6925.0926.21
Reserves302415-7-15-878511676613368270
Borrowings0022768815456321
Other Liabilities25173871668438595999135228101
Trade Payables0.228.497.2110.9910.3216.2113.0330.0827.6859.3994.45102.4882.93
Total Liabilities556275877886227203163185296323398
Fixed Assets30335361636466646770695258
Gross Block34.0937.9459.9770.5375.4579.5984.5786.9896.38106.8277.2867.17
Accumulated Depreciation4.125.377.139.6512.5215.6519.0222.4929.5836.868.1215.44
CWIP01421101011324
Investments0000209760010108211
Other Assets2529182411216413296114216161106
Trade receivables024.480.510.52.634.2625.062819.899.1638.917.5610.17
Cash Equivalents0.010.110.525.355.156.56.726.5617.3412.7570.311.320.68
Loans n Advances25.284.1216.8318.352.257.4528.3488.8146.3266.5762.9563.120.55
Total Assets556275877886227203163185296323398

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Cash from Operating Activity-1-2025132-69-9537-41-44-128-183
Profit from operations-1.59-3.06-10.24-17.72-5.81-69.37-16.7835.23-34.79-60.75-120.18-242.15
Working Capital Changes1.04-17.1736.1130.268.140.71-77.919.8-3.7430.4112.8620.48
Taxes paid0-0.16-0.420.1-0.03-0.79-0.65-8.13-2.64-13.87-20.72-10.08
Cash from Investing Activity120-26-12-8-2-994453-13-7-105
Fixed Assets Purchased0-4.51-26.23-8.18-4.73-4.51-3.6-3.67-8.09-12.33-8.58-32.63
Fixed Assets Sold00.020.070.030.050.120.040.070.180.520.1614.95
Investments purchased0000-11.10-173.43-588.58-38.5-16.8-36.95-559.15
Investments sold00008.65077.39683.6245.2216.8527.55465.4
Cash from Financing Activity0010472194-81-151194224
Proceeds from Shares000000186.530.540.020.1249.51133.33
Proceeds from Borrowings00.431.292.134.4662.887831.104900
Repayment of Borrowings000-1.720-1.15-69.97-102.14-0.972.5400
Interest Paid0-0.02-0.24-0.13-0.05-0.08-0.51-9.04-0.31-1.5-2.65-0.13
Net Cash Flow-0001-10-0-011-760-63

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
ROCE %-7%-10%-29%-79%-59%-1,034%-20%21%-32%-71%-95%-195%
Debtor Days2395516541056147217882
Inventory Turnover

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Sun Pharma Advanced Research Company Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.